Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 27, 01:22 AM 2012  
MYL WPI MRX PRX AKRX HITK 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for SLXP

Salix story

    
    

Salix Pharmaceuticals Ltd.

 Stock@American Stock Exchange 
United States
    
Use Salix Pharmaceuticals Ltd. story together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
    
    

Higher One Opens Office in Atlanta


Founded in 2000 on a college campus, Higher One is a technology and payment services company solely focused on higher education. Today, Higher One serves college and universities by helping business offices eliminate unnecessary costs while providing ... HIGHER ONE HOLDINGS, INC : Higher One Opens Office in Atlanta - 4-traders

Story Momentum

    
This story from www.bradenton.com contributed to next trading day price decline. The story delta to the next closing price was 0.73% . The story delta to the current price is 7.76% . story delta down: SLXP
Price
 
Timeline

Similar stores for Salix

    
Few days ago at www.itbusinessnet.com      

Analyst Moves: SLXP, WYNN

IT Business Net - May 10, 2012 By GrabNetworks Salix Pharmaceuticals (SLXP) today had its estimates increased by Jefferies (JEF) after the company beat earnings estimates.
Few days ago at zolmax.com      

Zacks Reiterates Neutral on Salix Pharmaceuticals (SLXP)

Junction Report - May 9, 2012 Salix Pharmaceuticals (NASDAQ: SLXP)'s stock had its ?neutral? rating restated by Zacks in a report issued on Wednesday. They currently have a $55.00 target price on the stock. Auriga Reiterates Hold on Salix Pharmaceuticals (SLXP) - Movie News Guide (blog)
Few days ago at www.streetinsider.com      

Jefferies Boosts Price Target on Salix Pharmaceuticals (SLXP)

StreetInsider.com (subscription) - May 8, 2012 Jefferies analysts raised their price target on Salix Pharmaceuticals (NASDAQ: SLXP) from $54.00 to $63.00 while maintaining a BUY rating on the company.
    
    

Discuss Salix story

       
       
    
Follow Salix News with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Salix to your reader
 
Get social with Salix News
 Salix News 
Share Toggle social options for Salix News
    

Salix Research Report

    
    

Short Ratio Comparison

Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting